{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T11:06:27Z","timestamp":1763809587641,"version":"3.41.2"},"reference-count":56,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10,1]]},"abstract":"<jats:sec><jats:title>OBJECTIVE:<\/jats:title><jats:p>Whether neonatal hyperbilirubinemia and\/or phototherapy increase the risk of autism spectrum disorder (ASD) is unclear. We sought to quantify the risk of ASD associated with elevated total serum bilirubin (TSB) levels and with phototherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>In a retrospective cohort study of 525\u2009409 infants born at \u226535 weeks\u2019 gestation in 15 Kaiser Permanente Northern California (KPNC) hospitals, 1995\u20132011, we obtained all TSB levels and determined which infants received phototherapy. From the KPNC Autism Registry, we identified patients with ASD diagnosed at a KPNC Autism Center, by a clinical specialist, or by a pediatrician. We calculated Cox proportional hazard ratios (HRs) for time to diagnosis of ASD, adjusting for confounding factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>Among infants in the birth cohort, 2% had at least 1 TSB level \u226520 mg\/dL, and 8% received phototherapy. The rate of ASD was 13 per 1000 births. Crude analyses revealed an association between TSB \u226520 and ASD (relative risk: 1.4; 95% confidence interval [CI]: 1.1\u20131.6), and between phototherapy and ASD (relative risk: 1.7; 95% CI: 1.5\u20131.8). After adjusting for confounders, TSB \u226520 (HR: 1.09; 95% CI: 0.89\u20131.35) and phototherapy (HR: 1.10; 95% CI: 0.98\u20131.24) were no longer significantly associated with ASD. Independent risk factors for ASD included maternal and paternal age; maternal and paternal higher education; male sex; birth weight &amp;lt;2500 g or \u22654200 g; and later year of birth.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>After adjustment for the effects of sociodemographic factors and birth weight, neither hyperbilirubinemia nor phototherapy was an independent risk factor for ASD.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.2016-1813","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T09:07:29Z","timestamp":1474880849000},"source":"Crossref","is-referenced-by-count":20,"title":["Risk of Autism Associated With Hyperbilirubinemia and Phototherapy"],"prefix":"10.1542","volume":"138","author":[{"given":"Yvonne W.","family":"Wu","sequence":"first","affiliation":[{"name":"Departments of Neurology,"},{"name":"Pediatrics, and"},{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Kuzniewicz","sequence":"additional","affiliation":[{"name":"Pediatrics, and"},{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Croen","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen M.","family":"Walsh","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"McCulloch","sequence":"additional","affiliation":[{"name":"Epidemiology and Biostatistics, University of California, San Francisco, California; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Newman","sequence":"additional","affiliation":[{"name":"Pediatrics, and"},{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"},{"name":"Epidemiology and Biostatistics, University of California, San Francisco, California; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"issue":"7","key":"2021120904475074700_B1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/mp.2009.143","article-title":"The Autism Birth Cohort: a paradigm for gene-environment-timing research.","volume":"15","author":"Stoltenberg","year":"2010","journal-title":"Mol Psychiatry"},{"key":"2021120904475074700_B2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.publhealth.28.021406.144007","article-title":"The epidemiology of autism spectrum disorders.","volume":"28","author":"Newschaffer","year":"2007","journal-title":"Annu Rev Public Health"},{"key":"2021120904475074700_B3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fpsyt.2014.00053","article-title":"Gene \u00d7 Environment interactions in autism spectrum disorders: role of epigenetic mechanisms.","volume":"5","author":"Tordjman","year":"2014","journal-title":"Front Psychiatry"},{"key":"2021120904475074700_B4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fneur.2015.00107","article-title":"The role of epigenetic change in autism spectrum disorders.","volume":"6","author":"Loke","year":"2015","journal-title":"Front Neurol"},{"issue":"11","key":"2021120904475074700_B5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s10803-010-1169-6","article-title":"Is neonatal jaundice associated with Autism Spectrum Disorders: a systematic review.","volume":"41","author":"Amin","year":"2011","journal-title":"J Autism Dev Disord"},{"issue":"2","key":"2021120904475074700_B6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1542\/peds.2010-1036","article-title":"Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis.","volume":"128","author":"Gardener","year":"2011","journal-title":"Pediatrics"},{"issue":"5","key":"2021120904475074700_B7","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1542\/peds.2010-0052","article-title":"Neonatal jaundice, autism, and other disorders of psychological development.","volume":"126","author":"Maimburg","year":"2010","journal-title":"Pediatrics"},{"key":"2021120904475074700_B8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpsychires.2014.03.019","article-title":"Prenatal and perinatal risk factors in a twin study of autism spectrum disorders.","volume":"54","author":"Froehlich-Santino","year":"2014","journal-title":"J Psychiatr Res"},{"key":"2021120904475074700_B9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/neuro.07.031.2009","article-title":"Incidence of pre-, peri-, and post-natal birth and developmental problems of children with sensory processing disorder and children with autism spectrum disorder.","volume":"3","author":"May-Benson","year":"2009","journal-title":"Front Integr Nuerosci"},{"issue":"9","key":"2021120904475074700_B10","first-page":"860","article-title":"Pregnancy, delivery, and neonatal complications among autistic children.","volume":"134","author":"Deykin","year":"1980","journal-title":"Am J Dis Child"},{"issue":"4","key":"2021120904475074700_B11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1542\/peds.86.4.514","article-title":"The UCLA-University of Utah epidemiologic survey of autism: prenatal, perinatal, and postnatal factors.","volume":"86","author":"Mason-Brothers","year":"1990","journal-title":"Pediatrics"},{"issue":"2","key":"2021120904475074700_B12","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2004-1870","article-title":"Neonatal hyperbilirubinemia and risk of autism spectrum disorders.","volume":"115","author":"Croen","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"2021120904475074700_B13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1542\/peds.2007-0967","article-title":"Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of &gt;or=325 micromol\/L (&gt;or=19 mg\/dL) who were born in Nova Scotia, Canada, between 1994 and 2000.","volume":"122","author":"Jangaard","year":"2008","journal-title":"Pediatrics"},{"issue":"6","key":"2021120904475074700_B14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-3016.2008.00973.x","article-title":"Neonatal jaundice: a risk factor for infantile autism?","volume":"22","author":"Maimburg","year":"2008","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"4","key":"2021120904475074700_B15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/dmcn.12603","article-title":"Follow-up of extreme neonatal hyperbilirubinaemia in 5- to 10-year-old children: a Danish population-based study.","volume":"57","author":"Vandborg","year":"2015","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"2021120904475074700_B16","doi-asserted-by":"crossref","DOI":"10.1542\/peds.107.4.e63","article-title":"Prenatal, perinatal, and neonatal factors in autism, pervasive developmental disorder-not otherwise specified, and the general population.","volume":"107","author":"Juul-Dam","year":"2001","journal-title":"Pediatrics"},{"issue":"2","key":"2021120904475074700_B17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1469-7610.1979.tb00492.x","article-title":"Pre-, peri-, and neonatal factors and infantile autism.","volume":"20","author":"Finegan","year":"1979","journal-title":"J Child Psychol Psychiatry"},{"issue":"11","key":"2021120904475074700_B18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/BF02726223","article-title":"Oxidative stress, phototherapy and the neonate.","volume":"67","author":"Gathwala","year":"2000","journal-title":"Indian J Pediatr"},{"issue":"11","key":"2021120904475074700_B19","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s004310051240","article-title":"Phototherapy for neonatal hyperbilirubinemia affects cytokine production by peripheral blood mononuclear cells.","volume":"158","author":"Sirota","year":"1999","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2021120904475074700_B20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/jp.2015.166","article-title":"Jaundice, phototherapy and DNA damage in full-term neonates.","volume":"36","author":"Ramy","year":"2016","journal-title":"J Perinatol"},{"issue":"3","key":"2021120904475074700_B21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/jamapediatrics.2014.3036","article-title":"Risk for cerebral palsy in infants with total serum bilirubin levels at or above the exchange transfusion threshold: a population-based study.","volume":"169","author":"Wu","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"3","key":"2021120904475074700_B22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1542\/peds.2014-3357","article-title":"Risk of sensorineural hearing loss and bilirubin exchange transfusion thresholds.","volume":"136","author":"Wickremasinghe","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"2021120904475074700_B23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ajog.2008.04.044","article-title":"Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders.","volume":"199","author":"Croen","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021120904475074700_B24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archpedi.159.2.151","article-title":"Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study.","volume":"159","author":"Croen","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"2021120904475074700_B25","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2006-1788","article-title":"Infection in the first 2 years of life and autism spectrum disorders.","volume":"119","author":"Rosen","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"2021120904475074700_B26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1005592401947","article-title":"The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.","volume":"30","author":"Lord","year":"2000","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"2021120904475074700_B27","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1542\/peds.2008-1635","article-title":"Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines.","volume":"123","author":"Newman","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"2021120904475074700_B28","doi-asserted-by":"crossref","first-page":"e20151354","DOI":"10.1542\/peds.2015-1354","article-title":"Retrospective cohort study of phototherapy and childhood cancer in northern California.","volume":"137","author":"Newman","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"2021120904475074700_B29","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1542\/peds.2008-2980","article-title":"Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use.","volume":"124","author":"Kuzniewicz","year":"2009","journal-title":"Pediatrics"},{"issue":"8","key":"2021120904475074700_B30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamapediatrics.2014.210","article-title":"Costs of autism spectrum disorders in the United Kingdom and the United States.","volume":"168","author":"Buescher","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"11","key":"2021120904475074700_B31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archgenpsychiatry.2011.76","article-title":"Genetic heritability and shared environmental factors among twin pairs with autism.","volume":"68","author":"Hallmayer","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"23","key":"2021120904475074700_B32","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs.","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"2021120904475074700_B33","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.reprotox.2006.03.015","article-title":"Prenatal exposure to misoprostol and congenital anomalies: systematic review and meta-analysis.","volume":"22","author":"da Silva Dal Pizzol","year":"2006","journal-title":"Reprod Toxicol"},{"issue":"9","key":"2021120904475074700_B34","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1289\/ehp.9120","article-title":"Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco bay area.","volume":"114","author":"Windham","year":"2006","journal-title":"Environ Health Perspect"},{"issue":"10","key":"2021120904475074700_B35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cppeds.2014.06.001","article-title":"Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence.","volume":"44","author":"Kalkbrenner","year":"2014","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"4","key":"2021120904475074700_B36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00001648-200207000-00009","article-title":"Perinatal risk factors for infantile autism.","volume":"13","author":"Hultman","year":"2002","journal-title":"Epidemiology"},{"issue":"3","key":"2021120904475074700_B37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0412.2011.01325.x","article-title":"Pre-, peri- and neonatal risk factors for autism.","volume":"91","author":"Guinchat","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"2021120904475074700_B38","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1016\/j.ridd.2013.06.019","article-title":"Prenatal, perinatal and neonatal risk factors of Autism Spectrum Disorder: a comprehensive epidemiological assessment from India.","volume":"34","author":"Mamidala","year":"2013","journal-title":"Res Dev Disabil"},{"issue":"1-2","key":"2021120904475074700_B39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.psychres.2014.05.057","article-title":"Perinatal and background risk factors for childhood autism in central China.","volume":"220","author":"Duan","year":"2014","journal-title":"Psychiatry Res"},{"issue":"3","key":"2021120904475074700_B40","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-3769A","article-title":"Jaundice-autism link unconvincing.","volume":"127","author":"Newman","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"2021120904475074700_B41","first-page":"1","article-title":"Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010.","volume":"63","author":"Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators","year":"2014","journal-title":"MMWR Surveill Summ"},{"issue":"10","key":"2021120904475074700_B42","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s10803-010-1160-2","article-title":"Birth prevalence of autism spectrum disorders in the San Francisco Bay area by demographic and ascertainment source characteristics.","volume":"41","author":"Windham","year":"2011","journal-title":"J Autism Dev Disord"},{"issue":"9","key":"2021120904475074700_B43","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/aje\/kwp247","article-title":"Risk of autism and increasing maternal and paternal age in a large North American population.","volume":"170","author":"Grether","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"1","key":"2021120904475074700_B44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpeds.2013.09.021","article-title":"Prevalence and neonatal factors associated with autism spectrum disorders in preterm infants.","volume":"164","author":"Kuzniewicz","year":"2014","journal-title":"J Pediatr"},{"issue":"6","key":"2021120904475074700_B45","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-1057","article-title":"A national profile of the health care experiences and family impact of autism spectrum disorder among children in the United States, 2005-2006.","volume":"122","author":"Kogan","year":"2008","journal-title":"Pediatrics"},{"issue":"12","key":"2021120904475074700_B46","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/00004583-200212000-00016","article-title":"Race differences in the age at diagnosis among Medicaid-eligible children with autism.","volume":"41","author":"Mandell","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"2021120904475074700_B47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/adc.2004.062083","article-title":"Systematic review of prevalence studies of autism spectrum disorders.","volume":"91","author":"Williams","year":"2006","journal-title":"Arch Dis Child"},{"issue":"6","key":"2021120904475074700_B48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1203\/PDR.0b013e31819e7203","article-title":"Epidemiology of pervasive developmental disorders.","volume":"65","author":"Fombonne","year":"2009","journal-title":"Pediatr Res"},{"issue":"4","key":"2021120904475074700_B49","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1542\/peds.2005-1516","article-title":"The contribution of diagnostic substitution to the growing administrative prevalence of autism in US special education.","volume":"117","author":"Shattuck","year":"2006","journal-title":"Pediatrics"},{"issue":"3","key":"2021120904475074700_B50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mrdd.10029","article-title":"The epidemiology of autistic spectrum disorders: is the prevalence rising?","volume":"8","author":"Wing","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"3","key":"2021120904475074700_B51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/jamapediatrics.2014.3036","article-title":"Risk for cerebral palsy in infants with total serum bilirubin levels at or above the exchange transfusion threshold: a population-based study.","volume":"169","author":"Wu","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"21","key":"2021120904475074700_B52","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMra1308124","article-title":"Bilirubin-induced neurologic damage--mechanisms and management approaches.","volume":"369","author":"Watchko","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120904475074700_B53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.siny.2009.12.004","article-title":"Chronic bilirubin encephalopathy: diagnosis and outcome.","volume":"15","author":"Shapiro","year":"2010","journal-title":"Semin Fetal Neonatal Med"},{"issue":"3","key":"2021120904475074700_B54","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-2825","article-title":"Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study.","volume":"128","author":"Ozonoff","year":"2011","journal-title":"Pediatrics"},{"issue":"7","key":"2021120904475074700_B55","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s10803-015-2358-0","article-title":"Validation of autism spectrum disorder diagnoses in large healthcare systems with electronic medical records.","volume":"45","author":"Coleman","year":"2015","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"2021120904475074700_B56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/EDE.0000000000000290","article-title":"Breastfeeding and autism spectrum disorder in the National Survey of Children\u2019s Health.","volume":"26","author":"Husk","year":"2015","journal-title":"Epidemiology"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-1813\/1063030\/peds_20161813.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-1813\/1063030\/peds_20161813.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T04:46:16Z","timestamp":1657341976000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/138\/4\/e20161813\/52327\/Risk-of-Autism-Associated-With-Hyperbilirubinemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,10,1]]},"published-print":{"date-parts":[[2016,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2016-1813","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2016,10,1]]},"article-number":"e20161813"}}